Literature DB >> 17613781

Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.

Simon He, Andrew Roberts, David Ritchie, Andrew Grigg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613781     DOI: 10.1080/10428190701400071

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  7 in total

1.  Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.

Authors:  Mariko Yabe; L Jeffrey Medeiros; Yahya Daneshbod; Masoud Davanlou; Carlos E Bueso-Ramos; Elisa J Moran; Ken H Young; Roberto N Miranda
Journal:  Ann Diagn Pathol       Date:  2016-10-18       Impact factor: 2.090

Review 2.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

3.  Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.

Authors:  Martin H Voss; Matthew A Lunning; Jocelyn C Maragulia; Esperanza B Papadopoulos; Jenna Goldberg; Andrew D Zelenetz; Steven M Horwitz
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-10-27

4.  Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.

Authors:  Eric Schafer; Allen Chen; Robert J Arceci
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

5.  Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma.

Authors:  A Rashidi; A F Cashen
Journal:  Blood Cancer J       Date:  2015-06-05       Impact factor: 11.037

6.  Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.

Authors:  Saranya A Selvaraj; Elizabeth Chairez; Lisa M Wilson; Mark Lazarev; Eric B Bass; Susan Hutfless
Journal:  Syst Rev       Date:  2013-07-05

7.  Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma.

Authors:  Gioacchino Catania; Francesco Zallio; Federico Monaco; Maria Teresa Corsetti; Nicol Trincheri; Lisa Bonello; Lia Mele; Franco Dallavalle; Flavia Salvi; Massimo Pini
Journal:  Leuk Res Rep       Date:  2014-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.